Filing Details

Accession Number:
0001235802-19-000134
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-20 16:52:06
Reporting Period:
2019-11-18
Accepted Time:
2019-11-20 16:52:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492658 Wright Medical Group N.v. WMGI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218011 D. Julie Dewey 1023 Cherry Road
Memphis TN 38117
Svp, Chief Comm. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 16,341 $17.79 42,899 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 987 $17.70 43,886 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 7,324 $20.75 51,210 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 1,776 $22.55 52,986 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 8,232 $23.93 61,218 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 54,437 $20.62 115,655 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 19,997 $21.24 135,652 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 6,983 $27.86 142,635 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-11-18 3,892 $24.49 146,527 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Disposition 2019-11-18 119,969 $29.49 26,558 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 16,341 $0.00 16,341 $17.79
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 987 $0.00 987 $17.70
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 7,324 $0.00 7,324 $20.75
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 1,776 $0.00 1,776 $22.55
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 8,232 $0.00 8,232 $23.93
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 54,437 $0.00 54,437 $20.62
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 19,997 $0.00 19,997 $21.24
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 6,983 $0.00 6,983 $27.86
Ordinary Shares Stock Option (right to buy) Disposition 2019-11-18 3,892 $0.00 3,892 $24.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-10-17 No 4 M Direct
0 2022-04-16 No 4 M Direct
0 2022-05-09 No 4 M Direct
0 2023-04-17 No 4 M Direct
0 2023-05-14 No 4 M Direct
0 2025-10-13 No 4 M Direct
4,642 2026-07-19 No 4 M Direct
5,443 2027-07-25 No 4 M Direct
8,568 2028-07-24 No 4 M Direct
Footnotes
  1. Exercise and sale of vested stock options in connection with 280G tax planning.
  2. Includes 2,144 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,588 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,616 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.51, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. This option has fully vested.
  5. This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
  6. This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
  7. This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.